During the past decade, Klinikum Frankfurt Höchst conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 17 clinical trials were completed, i.e. on average, 89.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Frankfurt Höchst" #1 sponsor was "AGO Study Group" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "AGO Research GmbH" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Frankfurt Höchst" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Nordic Society of Gynaecological Oncology - Clinical Trials Unit" with 2 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Frankfurt Höchst" are "Ovarian Cancer" (6 trials), "Fallopian Tube Cancer" (5 trials), "Breast Cancer" (4 trials), "Atrial Fibrillation" (3 trials) and "Acute Myeloid Leukemia (AML)" (2 trials). Many other conditions were trialed in "Klinikum Frankfurt Höchst" in a lesser frequency.

Most popular intervention types in "Klinikum Frankfurt Höchst" are "Drug" (33 trials), "Biological" (4 trials), "Other" (4 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "carboplatin" (4 trials), "Cyclophosphamide" (3 trials), "paclitaxel" (3 trials) and "5-Fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Frankfurt Höchst" are 32 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Klinikum Frankfurt Höchst". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Klinikum Frankfurt Höchst, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Frankfurt Höchst, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Klinikum Frankfurt Höchst has several departments that took part in Clinical trials: "Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst" - 3 trials, "Klinikum Frankfurt Höchst GmbH; Klinik Innere Medizin 3 - Hämatologie, Onkologie, Palliativmedizin" - 2 trials